Regulation of plasma cytokine levels before and following the training interventions
CAD, comorbidity, T2D comorbidity, T2D
TYPE 2 DIABETES, CORONARY ARTERY DISEASE, CAD
All cytokines measured were detected in the totality of the samples (HIIT non‐T2D We found no effect of time (before and after training interventions consisting of HIIT or MICT) nor of the comorbidity with CAD and T2D on plasma IL‐1b, TNF‐a, and CRP concentrations (Figure Circulating cytokine concentrations in participants with coronary artery disease (CAD) with or without type 2 diabetes (T2D) in response to a high intensity interval training (HIIT)‐ or moderate intensity continuous training (MICT)‐based rehabilitation program. Plasma cytokine concentrations at rest in men with CAD without (non‐T2D) or with the T2D comorbidity (T2D) before (pre) and after (post) a supervised 12‐week training intervention consisting of either HIIT or MICT. (a) IL‐1β, (b) TNF‐α, and (c) CRP. HIIT non‐T2D group (black circle): Circulating cytokine concentrations in participants with coronary artery disease (CAD) with or without type 2 diabetes (T2D) in response to a high intensity interval training (HIIT)‐ or moderate intensity continuous training (MICT)‐based rehabilitation program. Plasma cytokine concentrations at rest in men with CAD without (non‐T2D) or with the T2D comorbidity (T2D) before (pre) and after (post) a supervised 12‐week training intervention consisting of either HIIT or MICT. (a) SPARC, (b) FGF21, (c) IL‐6, (d) IL‐8, (e) IL‐10, (f) IL‐13, (g) IL‐15, and (h) IL‐18. HIIT non‐T2D group (black circle): 